Self-assembling protein molecules are versatile materials for medical applications because their ability to form gels can be accelerated or retarded by variations in pH, as well as changes in temperature or ionic strength. These biomaterials, responsive to physiological conditions, can therefore be easily adapted for applications where their effectiveness depends on gelation kinetics, such as how quickly and under what stimuli they form gels.
Understanding gelation kinetics for protein hydrogels is important for assessing their utility in medical applications and in the future of biomaterials. For example, fast-gelling systems are clinically useful for in situ gelation for the delivery of drugs or genetic material to target cells or anatomic regions, while slower-gelling systems are applicable for tissue engineering because of their ability to maintain cell viability and their propensity to maintain homogeneity… Continue reading.
Brooklyn Bioscience, a startup company commercializing university research to detoxify a common and dangerous class of pesticides, recently received another round of funding – this time in the form of a $250,000 grant from the National Science Foundation.
The New York University School of Engineering team behind Brooklyn Bioscience is engineering proteins to remediate and detoxify organophosphates (OPs), which cannot easily be removed by conventional means.
The two-year grant, part of the NSF’s Partnership for Innovation program, was awarded to the startup whose principals include Jin Kim Montclare, a professor of chemical and biomolecular engineering at the NYU Tandon School of Engineering and doctoral candidate Andrew Olsen… Continue reading.
WASHINGTON, D.C.—The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Jin Kim Montclare, Ph.D., Professor, Chemical and Biomolecular Engineering, Director of the Convergence for Innovation and Entrepreneurship Institute, Associate Director for Technology Advancement, New York University MRSEC, NYU Tandon School of Engineering, to its College of Fellows.
Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”
Dr. Montclare was nominated, reviewed, and elected by peers and members of the College of Fellows for “outstanding contributions to biomaterials and biocatalyst design via synthetic biology and protein engineering.”